Prevalence and prognostic significance of FLT3 gene mutations in patients with acute leukaemia: Analysis of patients from the Shanghai leukaemia co-operative groupa

Journal of International Medical Research

Volumn 38, Issue 2, 2010, Pages 432-442

  Wang, W ^a   Wang, X Q ^a   Xu, X P ^a   Lin, G W ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Acute leukaemia; FAB classification system; FLT3 gene; Mutation; Prognostic factors; WHO classification system

Indexed keywords

CD135 ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; CHINA; CONTROLLED STUDY; DISEASE FREE SURVIVAL; GENE DUPLICATION; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS;

EID: 77953710795     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800206     Document Type: Article

References (20)

1. Naoe T, KiyoiH: Normal and oncogenlc FLT3. Cell Mol Life Sci 2004; 61: 2932-2938.
2. Stirewalt DL, Radich JP: The role of FLT3 in haematopoietic malignancies. Nat Rev Cancer 2003; 3: 650-665.
3. Hayakawa F, Towatari M, Kiyoi H, et al: Tandem duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines. Oncogene 2000; 19: 624-631.
4. Yamamoto Y, Kiyoi H, Nakano Y, et al: Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood 2001; 97: 2434-2439.
5. Meshinchi S, Woods WG, Stirewalt DL, et al: Prevalence and prognostic significance of FLT3 internal tandem duplication in pediatric acute myeloid leukemia. Blood 2001; 97: 89-94.
6. Whitman SP, Archer KJ, Feng L, et al: Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. Cancer Res 2001; 61: 7233-7239.
7. Schlenk RF, Döhner K, Krauter J, et al: Mutations and treatment outcomes in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008; 358: 1909-1918.
8. Wang LH, Zhou CL, Zhang XW, et al: Prevalence and clinical significance of FLT3 internal tandem duplication mutation in acute leukemia. Zhonghua Xue Ye Xue Za Zhi 2004; 25: 393-396 [in Chinese].
9. Bennett JM, Catovsky D, Daniel MT, et al: Proposals for the classification of the acute leukemias. French-American-British (FAB) cooperative group. Br J Haematol 1976; 33: 451-458.
10. Brunning RD, Matutes E, Harris NL, et al: Acute myeloid leukemias. In: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues Gaffe ES, Harris NL, Stein H, et al, eds). Lyon: IARC Press, 2001; pp 75-107.
11. Kottaridis PD, Gale RE, Frew ME, et al: The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood 2001; 98: 1752-1759.
12. Wanf YG, Liu XH, Liang Y, et al: Correlation of FLT3 gene expression level and internal tandem duplication mutation in acute myeloid leukemia and its clinical significance. Zhonghua Xue Ye Xue Za Zhi 2008; 29: 741-745.
13. Colovic N, Tosic N, Aveic S, et al: Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia. Ann Hematol 2007; 86: 741-747.
14. Schnittger S, Schoch C, Drgas M, et al: Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia (AML): correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study, and usefulness as a marker for detection of minimal residual disease. Blood 2002; 100: 59-66.
15. Thiede C, Steudel C, Mohr B, et al: Analysis of FL13-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 2002; 99: 4326-4335.
16. Rombouts WJ, Blokland I, Löwenberg B, et al: Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene. Leukemia 2000; 14:675-683.
17. Kiyoi H, Naoe T, Nakano Y, et al: Prognostic implication of FLT3 and N-MS gene mutations in acute myeloid leukemia. Blood 1999; 93: 3074-3080.
18. Schnittger S, Schoch C, Kern W, et al: Flt3 length mutations in AML: correlation to cytogenetics, FAB-subtype, and prognosis in 652 patients. Blood 2000; 96: 826a [abstract].
19. Moreno I, Martín G, Bolufer P, et al: Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia. Haematologica 2003; 88: 19-24.
20. Preisler HD, Rustum Y, Henderson ES, et al: Treatment of acute nonlymphocytic leukemia: use of anthracycline-cytosine arabinoside induction therapy and comparison of two maintenance regimens. Blood 1979; 53: 455-464.